Dasatinib impurity 29, identified by its CAS number 1417651-54-7, is a chemical compound that serves as an impurity associated with the pharmaceutical agent dasatinib, which is primarily used in the treatment of certain types of leukemia. As an impurity, it may arise during the synthesis or degradation of dasatinib and can impact the purity and efficacy of the final product. The characteristics of this compound typically include its molecular structure, which is derived from the parent compound, and its physical properties such as solubility, melting point, and stability under various conditions. Impurities like Dasatinib impurity 29 are critical to monitor in pharmaceutical formulations, as they can affect the safety and effectiveness of the drug. Regulatory agencies often require detailed characterization and quantification of such impurities to ensure compliance with safety standards. Analytical techniques such as HPLC, mass spectrometry, and NMR spectroscopy are commonly employed to identify and quantify impurities in pharmaceutical substances.

Dasatinib impurity 29

1417651-54-7: Dasatinib impurity 29, identified by its CAS number 1417651-54-7, is a chemical compound that serves as an impurity associated with the pharmaceutical agent dasatinib, which is primarily used in the treatment of certain types of leukemia. As an impurity, it may arise during the synthesis or degradation of dasatinib and can impact the purity and efficacy of the final product. The characteristics of this compound typically include its molecular structure, which is derived from the parent compound, and its physical properties such as solubility, melting point, and stability under various conditions. Impurities like Dasatinib impurity 29 are critical to monitor in pharmaceutical formulations, as they can affect the safety and effectiveness of the drug. Regulatory agencies often require detailed characterization and quantification of such impurities to ensure compliance with safety standards. Analytical techniques such as HPLC, mass spectrometry, and NMR spectroscopy are commonly employed to identify and quantify impurities in pharmaceutical substances.

CAS 1417651-54-7

Dasatinib impurity 29

Dasatinib Impurity 42

Ref: ST-EA-CP-D1045